TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 2 | 10 | 23 | 21 | -7 | -27 | 4 |
| S | %wins | 0 | 0 | 0 | 0 | 100 | 100 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/03 18:38 | 10/29/03 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Marques Nelson R A | CA | O | CVP,P,La | M.d | 965 | 41.89 | 30 | 23 | 15 | D | -22 | 40 | 34 | -4 | -14 | -7 | -6 | -5 | 2 | 10 | 23 | 21 | -7 | -27 | |
10/30/03 18:38 | 10/29/03 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Marques Nelson R A | CA | O | CVP,P,La | S.d | -1,761 | 76.44 | 30 | -23 | -60 | 15 | D | -22 | 40 | 34 | -4 | -14 | -7 | -6 | -5 | 2 | 10 | 23 | 21 | -7 | -27 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |